Cargando…

Late Onset Clozapine Induced Agranulocytosis

Agranulocytosis is defined as an absolute neutrophil count less than 100/mm(3) in association with infectious disease. The risk of agranulocytosis is 0.38% of all clozapine treated cases and there is a relatively lesser incidence in Indian population. The risk of clozapine-induced agranulocytosis an...

Descripción completa

Detalles Bibliográficos
Autores principales: Velayudhan, Rajmohan, Kakkan, Sushil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4201798/
https://www.ncbi.nlm.nih.gov/pubmed/25336778
http://dx.doi.org/10.4103/0253-7176.140738
_version_ 1782340230438715392
author Velayudhan, Rajmohan
Kakkan, Sushil
author_facet Velayudhan, Rajmohan
Kakkan, Sushil
author_sort Velayudhan, Rajmohan
collection PubMed
description Agranulocytosis is defined as an absolute neutrophil count less than 100/mm(3) in association with infectious disease. The risk of agranulocytosis is 0.38% of all clozapine treated cases and there is a relatively lesser incidence in Indian population. The risk of clozapine-induced agranulocytosis and neutropenia is highest in the first 6 months and higher in the initial 18 months after the onset of treatment. There have been very few reports of neutropenia and agranulocytosis after this period. There have so far been no reports of late onset clozapine induced agranulocytosis has been reported from India. A case of late onset clozapine induced agranulocytosis with possible mechanism of the same is reported.
format Online
Article
Text
id pubmed-4201798
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-42017982014-10-21 Late Onset Clozapine Induced Agranulocytosis Velayudhan, Rajmohan Kakkan, Sushil Indian J Psychol Med Case Report Agranulocytosis is defined as an absolute neutrophil count less than 100/mm(3) in association with infectious disease. The risk of agranulocytosis is 0.38% of all clozapine treated cases and there is a relatively lesser incidence in Indian population. The risk of clozapine-induced agranulocytosis and neutropenia is highest in the first 6 months and higher in the initial 18 months after the onset of treatment. There have been very few reports of neutropenia and agranulocytosis after this period. There have so far been no reports of late onset clozapine induced agranulocytosis has been reported from India. A case of late onset clozapine induced agranulocytosis with possible mechanism of the same is reported. Medknow Publications & Media Pvt Ltd 2014 /pmc/articles/PMC4201798/ /pubmed/25336778 http://dx.doi.org/10.4103/0253-7176.140738 Text en Copyright: © Indian Journal of Psychological Medicine http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Velayudhan, Rajmohan
Kakkan, Sushil
Late Onset Clozapine Induced Agranulocytosis
title Late Onset Clozapine Induced Agranulocytosis
title_full Late Onset Clozapine Induced Agranulocytosis
title_fullStr Late Onset Clozapine Induced Agranulocytosis
title_full_unstemmed Late Onset Clozapine Induced Agranulocytosis
title_short Late Onset Clozapine Induced Agranulocytosis
title_sort late onset clozapine induced agranulocytosis
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4201798/
https://www.ncbi.nlm.nih.gov/pubmed/25336778
http://dx.doi.org/10.4103/0253-7176.140738
work_keys_str_mv AT velayudhanrajmohan lateonsetclozapineinducedagranulocytosis
AT kakkansushil lateonsetclozapineinducedagranulocytosis